Company Name, Ticker, Competitors, else..

Valuation Comparisons

Management Effectiveness

Financial Strength

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Aligos Therapeutics Inc (NASDAQ: ALGS)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Aligos Therapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics

Aligos Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.54, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2026. Aligos Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter,